(4881) Stock Price

Funpep is a pharmaceutical research and development company composed of Funpep Inc. and its subsidiary, Funpep Healthcare Inc. The company operates a single business segment focused on pharmaceutical research and development, with particular emphasis on functional peptide research and development.

Funpep advances functional peptide research and development based on research outcomes from the Graduate School of Medicine at Osaka University. Functional peptides have been applied across diverse fields including pharmaceuticals, cosmetics, and food products. The company aims to commercialize these peptides in the pharmaceutical field. Specifically, it is developing new pharmaceuticals using its drug discovery platform technology "STEP UP," which is based on antibody-inducing peptides.

The company's main development products include SR-0379, a skin ulcer treatment drug, and antibody-inducing peptides FPP003, FPP004X, and FPP005. These products are designed to provide therapeutic effects for specific diseases and aim to contribute to solving healthcare financing challenges. Additionally, Funpep advances its research and development process from early stages through commercialization through partnerships with pharmaceutical companies.

Funpep is a company that leverages proprietary peptide technology to address social challenges. Under its vision of "Bringing Vitality to the World with Peptides," the company is advancing product development that promotes physical and mental health. The company focuses particularly on drug discovery and development activities based on functional peptides.

The company's growth strategy centers on strengthening its technological capabilities in functional peptides and advancing research and development through partnerships with pharmaceutical companies. As a bioventure originating from Osaka University, Funpep serves as a bridge between university research outcomes and pharmaceutical companies, incubating technological seeds. This approach aims to enhance the value of developed products and achieve eventual commercialization.

Funpep builds partnerships with pharmaceutical companies from the early stages of research and development, pursuing a strategy that reduces financial risk while advancing R&D. The company plans to expand profits through royalty income generated when developed products reach the market. Additionally, Funpep aims for sustained growth by enriching its research and development pipeline and expanding new products and research themes.

The company actively pursues research and development funding through partnerships with pharmaceutical companies and capital market financing to secure necessary resources. Furthermore, Funpep is strengthening its organization by expanding talent in its research and development division and building efficient internal controls. Through these initiatives, Funpep aims to continue playing an important role in the pharmaceutical industry.